2026³â 07¿ù 01ÀÏ ¼ö¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Science & Technology

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

Arthur D. Little and Vega IT Unveil Joint Venture for Digital Innovation

´º½ºÀÏÀÚ: 2026-01-01

NEW YORK -- Arthur D. Little (ADL) and Vega IT announced the formation of Axceler8 Solutions, a 50/50 joint venture created to design, develop, and operate a portfolio of digital and AI solutions aimed at improving efficiency and automating complex business processes. The launch of this new company is the direct outcome of a year of successful collaboration between the two firms and marks a new phase in their shared ambition to bring scalable, high-performance digital solutions to market, aiming to further augment their clients’ capacity to compress time to impact in a variety of domains.

Axceler8 Solutions’ first product, Axceler8 Rx, is now live as a newly developed platform, and is a cloud-based application designed for pharmaceutical sponsors to accelerate clinical trial design, optimize country and site selection, and simulate patient enrolment. It combines ADL’s proprietary clinical trial IP and domain expertise with Vega IT’s software engineering capabilities and global experience in delivering innovative digital solutions in the healthcare sector. Key modules already delivered cover trial site selection, site activation, enrolment forecasting and an overall dashboard to visualize all aspects of clinical trial progress.

The underlying Axceler8 Rx platform is built on a modular, sector-agnostic architecture, enabling rapid development of future applications. This flexible foundation is designed to scale, supporting clients as they tackle evolving digital challenges. The two firms will work together to ensure a seamless global rollout of the platform, from providing consulting and commercialization expertise to systems integration and managed services.

Ignacio Garcia Alves, Chairman and CEO at Arthur D. Little, comments, “Axceler8 Solutions represents the next step in our partnership with Vega IT, one that turns powerful ideas into high-performance platforms. Together, we are bringing speed, scale, and intelligence to sectors that need it most, starting with life sciences.”

Sasa Popovic, CEO of Vega IT, adds, “Axceler8 Solutions is built for scale, speed, and impact. Our goal is to turn complexity into clarity for our clients, delivering smart, sector-ready solutions through a flexible, reusable platform.”

Philippe Mauchard, Chief Bridge Officer at Arthur D. Little concludes, “This joint venture is an important milestone in our Open Consulting strategy, strengthening our ability to equip clients for faster impact in AI and digital, through a set of complementary partnerships with leading organizations such as Vega IT.”



 Àüü´º½º¸ñ·ÏÀ¸·Î

Biocytogen Unveils AI-Powered RenSuper Platform and First Fully Automated Antibody Discovery System
Kwon Oh-tae from Donghae Aqua Unveils VINE7, a Seven-Day Vinegar Fermentation System
RevBits, Stony Brook Ethos Lab Partner to Advance Cybersecurity Education and Application
Silicon Motion Achieves ISO 26262 Certification for Automotive Applications
Poland¡¯s Poznan University of Technology Unveils IQM Quantum Computer to Drive Research and Education
ASC26 Student Supercomputer Challenge Concluded
2026 Esri User Conference to Focus on Creating a More Intelligent World with GIS

 

HistoSonics Treats First Patients Using Edison Histotripsy System for ...
Parse Biosciences and bit.bio Announce Landmark Alliance
ExaGrid Wins 5 Industry Awards at Network Computing Awards 2026
TestMu AI Introduces DevTools Assertions in Kane CLI, Enabling Browser...
Amazon, Netflix and Google to Capture Half of $81 Billion CTV Advertis...
Mevion Medical Systems Partners with Tam Anh General Hospital to Intro...
Comparative Absorption Study of Rice Bran-Derived ¡°Rice Magnesium¡± R...

 


°øÁö»çÇ×
¹Ìµð¾î¿Í M• Mediaour ØÚ体ä² ØÚô÷ä² ¿¥¿À MO ØÚä²
¾Ë¸®¾Ë A⋮⋮⋮ Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
À£ÇÁ·Ò W⋮⋮⋮ Welfrom 卫ÜØ êÛÝ£
¹ÙÀÌ¿ÀÀÌ´Ï B⋮ BIOINI ù±药研 ¹ÙÀÌ¿ÀÀÌ´Ï·¦ BIOINILAB ...
º£³×ÀÍ ¡Õ Beneik 宝Ò¬ìÌ, À̺ñÁî eBizh æ¶币òª EZ æ¶òª
¿¡³ÊÀÌÀ¯ ¡Õ¡Õ EnerEU 额Òö äþÒö
´º½ºÁö Áß¹®Ç¥±â´Â À½Â÷ Ç¥±â¹æ½Ä '纽ÞÙó¢ ´Ï¿ì½ºÁö'
¾Ë¸®À¯ºñ ^v Alliuv ä¹备 AV ä¹êó备, ¾Ë¶ã =^= Althle ä¹÷åìÌ
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º ¡ÕC À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¾ËÇÁ·Ò ^ Alfrom ä¹尔ÜØ ä¹ì³ÜØ, ¿ÃÇÁ·Ò A⋮⋮ Allfrom &...

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..